All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway

The proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neoi...

Full description

Bibliographic Details
Main Authors: Jingzhi Zhang, Bo Deng, Xiaoli Jiang, Min Cai, Ningning Liu, Shuangwei Zhang, Yongzhen Tan, Guiqiong Huang, Wen Jin, Bin Liu, Shiming Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00485/full
_version_ 1818260473636716544
author Jingzhi Zhang
Jingzhi Zhang
Bo Deng
Bo Deng
Xiaoli Jiang
Xiaoli Jiang
Min Cai
Min Cai
Ningning Liu
Shuangwei Zhang
Shuangwei Zhang
Yongzhen Tan
Guiqiong Huang
Wen Jin
Bin Liu
Bin Liu
Shiming Liu
author_facet Jingzhi Zhang
Jingzhi Zhang
Bo Deng
Bo Deng
Xiaoli Jiang
Xiaoli Jiang
Min Cai
Min Cai
Ningning Liu
Shuangwei Zhang
Shuangwei Zhang
Yongzhen Tan
Guiqiong Huang
Wen Jin
Bin Liu
Bin Liu
Shiming Liu
author_sort Jingzhi Zhang
collection DOAJ
description The proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neointimal hyperplasia effects of ATRA. We found that treatment with ATRA significantly reduced neointimal hyperplasia in the left common carotid artery ligation mouse model. ATRA reduced the proliferation and migration of VSMC, A7r5 and HASMC cell lines. Our results also demonstrated that ATRA altered the expression of proliferation-related proteins, including CyclinD1, CyclinD3, CyclinA2, CDK2, CDK4, and CDK6 in VSMC. ATRA dose-dependently enhanced the phosphorylation level of AMPKα (Thr172) in the left common carotid artery of experimental mice. Also, the phosphorylation level of AMPKα in A7r5 and HASMC was significantly increased. In addition, ATRA dose-dependently reduced the phosphorylation levels of mTOR and mTOR target proteins p70 S6 kinase (p70S6K) and 4E-binding protein 1 (4EBP1) in A7r5 and HASMC. Notably, the inhibition of AMPKα by AMPK inhibitor (compound C) negated the protective effect of ATRA on VSMC proliferation in A7r5. Also, knockdown of AMPKα by siRNA partly abolished the anti-proliferative and anti-migratory effects of ATRA in HASMC. Molecular docking analysis showed that ATRA could dock to the agonist binding site of AMPK, and the binding energy between AMPK and ATRA was -7.91 kcal/mol. Molecular dynamics simulations showed that the binding of AMPK-ATRA was stable. These data demonstrated that ATRA might inhibit neointimal hyperplasia and suppress VSMC proliferation and migration by direct activation of AMPK and inhibition of mTOR signaling.
first_indexed 2024-12-12T18:31:54Z
format Article
id doaj.art-56f839088b404cc79ae01a44c572daef
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-12T18:31:54Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-56f839088b404cc79ae01a44c572daef2022-12-22T00:15:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-05-011010.3389/fphar.2019.00485433471All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling PathwayJingzhi Zhang0Jingzhi Zhang1Bo Deng2Bo Deng3Xiaoli Jiang4Xiaoli Jiang5Min Cai6Min Cai7Ningning Liu8Shuangwei Zhang9Shuangwei Zhang10Yongzhen Tan11Guiqiong Huang12Wen Jin13Bin Liu14Bin Liu15Shiming Liu16Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Internal Medicine, Huizhou Hospital of Traditional Chinese Medicine, Huizhou, ChinaDepartment of Cardiology, Guangdong Second Provincial General Hospital, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaThe proliferation and migration of vascular smooth muscle cells (VSMC) is extensively involved in pathogenesis of neointimal hyperplasia. All-trans-retinoic acid (ATRA) is a natural metabolite of vitamin A. Here, we investigated the involvement of AMP-activated protein kinase (AMPK) in the anti-neointimal hyperplasia effects of ATRA. We found that treatment with ATRA significantly reduced neointimal hyperplasia in the left common carotid artery ligation mouse model. ATRA reduced the proliferation and migration of VSMC, A7r5 and HASMC cell lines. Our results also demonstrated that ATRA altered the expression of proliferation-related proteins, including CyclinD1, CyclinD3, CyclinA2, CDK2, CDK4, and CDK6 in VSMC. ATRA dose-dependently enhanced the phosphorylation level of AMPKα (Thr172) in the left common carotid artery of experimental mice. Also, the phosphorylation level of AMPKα in A7r5 and HASMC was significantly increased. In addition, ATRA dose-dependently reduced the phosphorylation levels of mTOR and mTOR target proteins p70 S6 kinase (p70S6K) and 4E-binding protein 1 (4EBP1) in A7r5 and HASMC. Notably, the inhibition of AMPKα by AMPK inhibitor (compound C) negated the protective effect of ATRA on VSMC proliferation in A7r5. Also, knockdown of AMPKα by siRNA partly abolished the anti-proliferative and anti-migratory effects of ATRA in HASMC. Molecular docking analysis showed that ATRA could dock to the agonist binding site of AMPK, and the binding energy between AMPK and ATRA was -7.91 kcal/mol. Molecular dynamics simulations showed that the binding of AMPK-ATRA was stable. These data demonstrated that ATRA might inhibit neointimal hyperplasia and suppress VSMC proliferation and migration by direct activation of AMPK and inhibition of mTOR signaling.https://www.frontiersin.org/article/10.3389/fphar.2019.00485/fullall-trans-retinoic acidneointimal hyperplasiavascular smooth muscle cellproliferationAMP-activated protein kinase
spellingShingle Jingzhi Zhang
Jingzhi Zhang
Bo Deng
Bo Deng
Xiaoli Jiang
Xiaoli Jiang
Min Cai
Min Cai
Ningning Liu
Shuangwei Zhang
Shuangwei Zhang
Yongzhen Tan
Guiqiong Huang
Wen Jin
Bin Liu
Bin Liu
Shiming Liu
All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
Frontiers in Pharmacology
all-trans-retinoic acid
neointimal hyperplasia
vascular smooth muscle cell
proliferation
AMP-activated protein kinase
title All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
title_full All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
title_fullStr All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
title_full_unstemmed All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
title_short All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
title_sort all trans retinoic acid suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation and migration via activation of ampk signaling pathway
topic all-trans-retinoic acid
neointimal hyperplasia
vascular smooth muscle cell
proliferation
AMP-activated protein kinase
url https://www.frontiersin.org/article/10.3389/fphar.2019.00485/full
work_keys_str_mv AT jingzhizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT jingzhizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT bodeng alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT bodeng alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT xiaolijiang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT xiaolijiang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT mincai alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT mincai alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT ningningliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT shuangweizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT shuangweizhang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT yongzhentan alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT guiqionghuang alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT wenjin alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT binliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT binliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway
AT shimingliu alltransretinoicacidsuppressesneointimalhyperplasiaandinhibitsvascularsmoothmusclecellproliferationandmigrationviaactivationofampksignalingpathway